These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6130655)

  • 1. [Use of Cordanum in labile hypertension].
    Gerasimiuk PP; Zaporozhets TF; Slobodianik GP
    Vrach Delo; 1982 Nov; (11):29-30. PubMed ID: 6130655
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of the cardioselective adrenergic beta 1-blockader cordanum in the treatment of arterial hypertension].
    Zonis BIa; Brin VB
    Ter Arkh; 1983; 55(5):81-3. PubMed ID: 6137077
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemodynamics of hypertension. Changes caused by beta-blocking agents].
    Mattioli G; Ricci S; Bertoncelli P
    Minerva Cardioangiol; 1979; 27(7-8):463-72. PubMed ID: 44898
    [No Abstract]   [Full Text] [Related]  

  • 4. [The antihypertensive effect of a new beta-adrenergic blocking drug metroprolol in combination with chlorthalidone].
    Jäättelä A; Pyöräiä K
    Duodecim; 1976; 92(11):597-603. PubMed ID: 7445
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of arotinolol hydrochloride on hemodynamics, catecholamine levels and metabolism in patients with essential hypertension].
    Morimoto Y; Kasai A; Nagano K; Umino M; Kakuta Y; Iwata J; Konishi T; Hamada M; Nakano T
    Kokyu To Junkan; 1988 Mar; 36(3):311-5. PubMed ID: 2453908
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in hemodynamics and renal function during the oral administration of betaxolol].
    Pathe M; Schwartz J
    Therapie; 1985; 40(4):209-12. PubMed ID: 2862715
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemodynamic correlates of selective beta 1 adrenergic receptor blockade by cordanum during hemiton monotherapy in children with primary arterial hypertension].
    Kapliev VA
    Pediatriia; 1988; (9):112. PubMed ID: 2904673
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical study of a new beta-adrenergic receptor blocking substance, indenolol].
    Cirino D; Savonelli C; Maggi GC
    Minerva Cardioangiol; 1983 Nov; 31(11):671-6. PubMed ID: 6142433
    [No Abstract]   [Full Text] [Related]  

  • 9. [Celiprolol efficacy and tolerance in the treatment of arterial hypertension].
    Lobos Bejarano JM; Granados Menéndez MI; del Valle González J; Bravo Juega P
    An Med Interna; 1991 Jan; 8(1):52-3. PubMed ID: 1680475
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical evaluation of betaxolol (Kerlone) as a once-daily treatment for hypertension in 4685 patients.
    Djian J
    Br J Clin Pract; 1985 May; 39(5):188-91. PubMed ID: 2866790
    [No Abstract]   [Full Text] [Related]  

  • 11. Nadolol, a once daily treatment for hypertension: multi-centre clinical evaluation.
    Jackson DA
    Br J Clin Pract; 1980 Jul; 34(7):211-21. PubMed ID: 6107120
    [No Abstract]   [Full Text] [Related]  

  • 12. [New aspects of antihypertensive therapy].
    Wedler B; Börner H; Schulz H; Teichmann G
    Ann Acad Med Stetin Supl; 1978; Suppl 16():9-12. PubMed ID: 44441
    [No Abstract]   [Full Text] [Related]  

  • 13. A long-term evaluation of nadolol, a long-acting beta-adrenergic blocking agent, in the management of hypertension in general practice.
    O'Callaghan EG
    Br J Clin Pract; 1982 Jun; 36(6):235-9. PubMed ID: 6128994
    [No Abstract]   [Full Text] [Related]  

  • 14. [Adrenergic beta receptor blockader celiprolol in the treatment of patients with arterial hypertension].
    Kapitanenko AM; Dulin PA
    Klin Med (Mosk); 1990 Feb; 68(2):65-9. PubMed ID: 2139911
    [No Abstract]   [Full Text] [Related]  

  • 15. Celiprolol, clinical dosage, efficacy and safety in asthmatic and elderly patients.
    Hitzenberger G
    Br J Clin Pract Suppl; 1985 Jun; 40():25-32. PubMed ID: 2864058
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antihypertensive effect of betaxolol at increasing doses].
    Pathe M; Steimer C; Schwartz J
    Therapie; 1982; 37(1):75-82. PubMed ID: 6124052
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intraindividual comparison of 2 bisoprolol dosages in patients with essential hypertension].
    Cardona R; Disselhoff G; Lizarraga P; Orozco M; Perez-Acuna F; Monsalve P; Vera O; Lopez B; Schmidt-Dommerque F; Tremarias A
    Med Klin (Munich); 1986 Apr; 81(9):307-10. PubMed ID: 2878358
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of celiprolol and atenolol in the treatment of hypertension.
    Rosenthal F; Silke B; Capone P
    Br J Clin Pract Suppl; 1985 Jun; 40():76-7. PubMed ID: 2864070
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of celiprolol and propranolol in the treatment of hypertension.
    Taylor S; Beattie A; Capone P
    Br J Clin Pract Suppl; 1985 Jun; 40():78-9. PubMed ID: 2864071
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical evaluation of the hypotensive effects of nadolol].
    Hanzlik J; Sodolski W; Stelmasiak T; Wolański I
    Kardiol Pol; 1982; 25(2):101-6. PubMed ID: 6125620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.